Ionis Pharmaceuticals | IONS - Assets


Ionis Pharmaceuticals reported $2.99B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Agios Pharmaceuticals USD 1.11B 76.57M Jun/2026
Alnylam Pharmaceuticals USD 5.56B 429.22M Jun/2026
Arrowhead Research USD 2.11B 156.25M Jun/2026
Astellas Pharma JPY 3.69T 125.48B Jun/2026
BioCryst Pharmaceuticals USD 557.85M 92.8M Jun/2026
BioMarin Pharmaceutical USD 8.59B 996.99M Mar/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Exelixis USD 2.59B 250.83M Mar/2026
Halozyme Therapeutics USD 2.67B 147.4M Mar/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Moderna USD 10.96B 527M Jun/2026
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Neurocrine Biosciences USD 5.36B 452.9M Jun/2026
Novartis USD 122.03B 3.5B Jun/2026
Omeros USD 200.57M 34.59M Jun/2025
OPKO Health USD 1.86B 75.15M Mar/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pfizer USD 201.13B 6.49B Jun/2026
Pharma Mar EUR 393.6M 8.34M Jun/2026
PTC Therapeutics USD 3.25B 381.37M Jun/2026
Qiagen NV USD 5.78B 513.9M Mar/2026
Regeneron Pharmaceuticals USD 41.73B 861.8M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sarepta Therapeutics USD 3.18B 170.77M Mar/2026
Sartorius EUR 9.6B 270.6M Jun/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tilray USD 2.1B 15.95M Sep/2025
Ultragenyx Pharmaceutical USD 1.26B 32M Jun/2026
Vertex Pharmaceuticals USD 27.42B 938.9M Jun/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026